4.5 Article

Proof of concept: Pull down assay using bovine serum albumin and an immunomodulator small molecule

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Rapid synthesis of bovine serum albumin-conjugated gold nanoparticles using pulsed laser ablation and their anticancer activity on hela cells

S. A. Abdulateef et al.

Summary: This study successfully synthesized gold nanoparticles using pulsed laser ablation technique and explored the effects of bovine serum albumin on particle stability and aggregation. The synthesized nanoparticles showed low toxicity and high biocompatibility, making them promising for therapeutic applications.

ARABIAN JOURNAL OF CHEMISTRY (2023)

Article Microbiology

Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals

Shima Shahbaz et al.

Summary: CD8(+) T cells play an important role in chronic viral infections, but the expression of CD73 is compromised and its function impaired in HIV infection. CD73 expression is decreased in HIV-infected individuals at both cell surface and gene levels. CD73(+) T cells exhibit functional impairments while showing enhanced migration capabilities.

PLOS PATHOGENS (2022)

Review Pharmacology & Pharmacy

Small molecule-based immunomodulators for cancer therapy

Yinrong Wu et al.

Summary: Immunotherapy has revolutionized cancer treatment, with current therapies mostly based on antibodies. However, these therapies have limitations in terms of pharmacokinetics and immunogenicity. To overcome these limitations, researchers have focused on developing small molecule-based immunotherapy. This review provides an overview of the progress in small molecule-based immunomodulators for cancer therapy, including targeting PD-1/PD-L1, chemokine receptors, STING, TLR, etc. The importance of combining small molecule-based immunomodulators with therapeutic antibodies is also highlighted.

ACTA PHARMACEUTICA SINICA B (2022)

Review Biochemistry & Molecular Biology

Tetrazine bioorthogonal chemistry derived in vivo imaging

Gaoxiang Zhao et al.

Summary: Bioorthogonal chemistry represents highly efficient and biocompatible reactions that proceed selectively and rapidly in biological situations. Tetrazine bioorthogonal reactions play an important role in in vivo imaging applications, allowing for the easy tracking of real signals through controlled fluorescence or radiation off-on mechanism.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Review Biochemistry & Molecular Biology

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

Dong-Rui Wang et al.

Summary: Cancers are complex diseases characterized by malignant cell overgrowth and altered immune response. Immunotherapy, including immune checkpoint blockade and adoptive cell transfer, has shown success in inducing long-term regression of refractory tumors. Combination therapy and biomarker discovery are important for improving the overall clinical response rate of tumor immunotherapy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Pharmacology & Pharmacy

Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations

Yasser Tabana et al.

Summary: T cell functions are altered during chronic viral infections and tumor development, leading them into an 'exhausted' state due to changes in epigenetic and metabolic landscapes. The discovery of immune checkpoints pathways has shown promising activities in reversing T cell exhaustion, with next-generation alternatives such as small molecules on the horizon to overcome associated limitations.

EXPERT OPINION ON THERAPEUTIC TARGETS (2021)

Article Multidisciplinary Sciences

Bioorthogonal chemistry

Samuel L. Scinto et al.

Summary: Bioorthogonal chemistry involves high-yielding chemical reactions in biological environments that are rapid and selective, playing essential roles in various fields such as biomedical imaging and drug delivery. Its applications are diverse and include genetic code expansion, drug target identification, and antibody-drug conjugation.

NATURE REVIEWS METHODS PRIMERS (2021)

Review Biochemistry & Molecular Biology

Recent advances in identifying protein targets in drug discovery

Jaeyoung Ha et al.

Summary: Phenotype-based screening is a promising method for discovering first-in-class therapeutics, but understanding the mode of action has been a bottleneck for drug discovery. Recent strategies including covalent conjugation and label-free target identification have emerged to overcome limitations in target protein identification, leading to significant advancements in the field.

CELL CHEMICAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Recent Advances in Chemical Biology Using Benzophenones and Diazirines as Radical Precursors

Muhammad Murtaza Hassan et al.

MOLECULES (2020)

Review Immunology

Opportunities for Small Molecules in Cancer Immunotherapy

Sabina Y. van der Zanden et al.

TRENDS IN IMMUNOLOGY (2020)

Article Spectroscopy

Interaction mechanism of flavonoids on bovine serum albumin: Insights from molecular property -binding affinity relationship

Hongjin Tang et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)

Article Pharmacology & Pharmacy

Interaction of repaglinide with bovine serum albumin: Spectroscopic and molecular docking approaches

Suma K. Pawar et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2019)

Article Multidisciplinary Sciences

Comprehensive in vitro characterization of PD-L1 small molecule inhibitors

Aravindhan Ganesan et al.

SCIENTIFIC REPORTS (2019)

Article Chemistry, Multidisciplinary

Target discovery of ebselen with a biotinylated probe

Zhenzhen Chen et al.

CHEMICAL COMMUNICATIONS (2018)

Article Chemistry, Multidisciplinary

Exploring the Binding Proteins of Glycolipids with Bifunctional Chemical Probes

Xiaohui Liu et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Review Chemistry, Medicinal

Photoaffinity labeling in target- and binding-site identification

Ewan Smith et al.

FUTURE MEDICINAL CHEMISTRY (2015)

Article Biotechnology & Applied Microbiology

Big opportunities for small molecules in immuno-oncology

Jerry L. Adams et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Biochemistry & Molecular Biology

A New Chemical Probe for Phosphatidylinositol Kinase Activity

Allison R. Sherratt et al.

CHEMBIOCHEM (2014)

Article Biochemistry & Molecular Biology

A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation

Sanghee Lee et al.

NATURE CHEMICAL BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Target identification and mechanism of action in chemical biology and drug discovery

Monica Schenone et al.

NATURE CHEMICAL BIOLOGY (2013)

Review Biochemistry & Molecular Biology

Tandem photoaffinity labeling-bioorthogonal conjugation in medicinal chemistry

David J. Lapinsky

BIOORGANIC & MEDICINAL CHEMISTRY (2012)

Editorial Material Chemistry, Multidisciplinary

GUEST EDITORIAL A Decade of Bioorthogonal Chemistry

Carolyn R. Bertozzi

ACCOUNTS OF CHEMICAL RESEARCH (2011)

Review Chemistry, Multidisciplinary

Bioorthogonal chemistry: a covalent strategy for the study of biological systems

Reyna K. Lim et al.

SCIENCE CHINA-CHEMISTRY (2010)

Article Multidisciplinary Sciences

A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation

HC Hang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Chemistry, Multidisciplinary

Bioconjugation by copper(I)-catalyzed azide-alkyne [3+2] cycloaddition

Q Wang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)